4N9-62160-71063
3 vaccinations
1 coded response
20 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 974 / OR
- Registered
- 2021-12-04
- Relationship
- Child or adolescent in my care
- Guardian
- QBN-32737-67774
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-13
Dose 1 — Pfizer-BioNTech
-
2021-12-04
Registered in v-safe
-
2021-12-04
Dose 2 — Pfizer-BioNTech
- 2021-12-04
-
2021-12-05
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-12-07
- 2021-12-08
- 2021-12-09
- 2021-12-11
- 2021-12-18
- 2021-12-25
- 2022-01-01
- 2022-01-08
- 2022-01-15
- 2022-03-05
- 2022-06-05
-
2022-11-15
Dose 3 — Pfizer-BioNTechCo-administered: Flu:HPV
- 2022-12-02
- 2022-12-06
-
2022-12-13
Survey response — day 28, dose 3, dependentMedDRA: Body temperature increased — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Mild fever of 99.6 for 24 hours weekMedDRA releases: 2024-11 · check-in free text available
- 2022-12-20
- 2022-12-27
- 2023-02-14
- 2023-05-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-13 | Pfizer-BioNTech | No |
| 2 | 2021-12-04 | Pfizer-BioNTech | No |
| 3 | 2022-11-15 | Pfizer-BioNTech | Flu:HPV |
Free text
Release 12 — day 28, dose 3, dependent
Symptoms: Mild fever of 99.6 for 24 hours week
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Body temperature increased | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release